Traws Pharma, Inc.
TRAW
21 insider filings · Latest: Jul 9, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Apr 29 1:41 AM | ORBIMED ADVISORS LLC10% Owner | Purchase | 597,729 | $1.67 | $998.2K | 1,203,250(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 8, 2026 | Mar 10 11:16 PM | Jack E StoverDirector | Grant/Award | 33,435 | $1.60 | 33,435(D) | View → |
| Mar 8, 2026 | Mar 10 11:15 PM | Robert RedfieldChief Medical Officer | Grant/Award | 108,854 | $1.60 | 108,854(D) | View → |
| Mar 8, 2026 | Mar 10 11:12 PM | Mary Teresa ShoemakerDirector | Grant/Award | 33,435 | $1.60 | 33,435(D) | View → |
← Previous
Page 2 of 2